E for L Aim Public Company Limited (EFORL) - Total Assets
Based on the latest financial reports, E for L Aim Public Company Limited (EFORL) holds total assets worth ฿1.14 Billion THB (≈ $35.38 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
E for L Aim Public Company Limited - Total Assets Trend (2007–2025)
This chart illustrates how E for L Aim Public Company Limited's total assets have evolved over time, based on quarterly financial data. Also see how much is E for L Aim Public Company Limited worth for the company's overall valuation and market capitalisation.
E for L Aim Public Company Limited - Asset Composition Analysis
Current Asset Composition (December 2025)
E for L Aim Public Company Limited's total assets of ฿1.14 Billion consist of 63.2% current assets and 36.8% non-current assets. Review E for L Aim Public Company Limited total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 1.9% |
| Accounts Receivable | ฿368.51 Million | 29.4% |
| Inventory | ฿399.74 Million | 31.9% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿13.51 Million | 1.1% |
| Goodwill | ฿0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how E for L Aim Public Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See E for L Aim Public Company Limited share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: E for L Aim Public Company Limited's current assets represent 63.2% of total assets in 2025, an increase from 12.1% in 2007.
- Cash Position: Cash and equivalents constituted 1.9% of total assets in 2025, down from 5.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 3.0% in 2007.
- Asset Diversification: The largest asset category is inventory at 31.9% of total assets.
E for L Aim Public Company Limited Competitors by Total Assets
Key competitors of E for L Aim Public Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998
|
China | CN¥112.28 Billion |
|
TELES Informationstechnologien AG
XETRA:TLIK
|
Germany | €4.29 Million |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥235.37 Billion |
E for L Aim Public Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.73 | 1.56 | 1.41 |
| Quick Ratio | 0.83 | 0.82 | 0.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿294.29 Million | ฿307.56 Million | ฿405.93 Million |
E for L Aim Public Company Limited - Advanced Valuation Insights
This section examines the relationship between E for L Aim Public Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.74 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -10.9% |
| Total Assets | ฿1.25 Billion |
| Market Capitalization | $13.71 Million USD |
Valuation Analysis
Below Book Valuation: The market values E for L Aim Public Company Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: E for L Aim Public Company Limited's assets decreased by 10.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for E for L Aim Public Company Limited (2007–2025)
The table below shows the annual total assets of E for L Aim Public Company Limited from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ฿1.25 Billion ≈ $39.05 Million |
-10.90% |
| 2024-12-31 | ฿1.41 Billion ≈ $43.83 Million |
+2.76% |
| 2023-12-31 | ฿1.37 Billion ≈ $42.65 Million |
-11.38% |
| 2022-12-31 | ฿1.54 Billion ≈ $48.13 Million |
-7.93% |
| 2021-12-31 | ฿1.68 Billion ≈ $52.28 Million |
+7.75% |
| 2020-12-31 | ฿1.56 Billion ≈ $48.52 Million |
-36.30% |
| 2019-12-31 | ฿2.44 Billion ≈ $76.17 Million |
-24.05% |
| 2018-12-31 | ฿3.22 Billion ≈ $100.28 Million |
-17.20% |
| 2017-12-31 | ฿3.89 Billion ≈ $121.11 Million |
-42.42% |
| 2016-12-31 | ฿6.75 Billion ≈ $210.33 Million |
-7.63% |
| 2015-12-31 | ฿7.31 Billion ≈ $227.71 Million |
-0.83% |
| 2014-12-31 | ฿7.37 Billion ≈ $229.60 Million |
+775.90% |
| 2013-12-31 | ฿840.99 Million ≈ $26.21 Million |
+1281.94% |
| 2012-12-31 | ฿60.86 Million ≈ $1.90 Million |
-62.07% |
| 2011-12-31 | ฿160.42 Million ≈ $5.00 Million |
-16.12% |
| 2010-12-31 | ฿191.26 Million ≈ $5.96 Million |
-38.92% |
| 2009-12-31 | ฿313.14 Million ≈ $9.76 Million |
-0.43% |
| 2008-12-31 | ฿314.47 Million ≈ $9.80 Million |
+31.76% |
| 2007-12-31 | ฿238.68 Million ≈ $7.44 Million |
-- |
About E for L Aim Public Company Limited
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia. The company offers medical devices, including patient and central monitor systems, defibrillator, automated external defibrillator, electrocardiographs, electroencephalogram, PSG system, and accessories and consumables, … Read more